1. Link between overweight/obese in children and youngsters and occurrence of multiple sclerosis

   • Thamina Rasul
   • Jette Lautrup Frederiksen

   Review 26 April 2018 Pages: 2755 - 2763

   

2. Dilemma of multiple system atrophy and spinocerebellar ataxias

   • Ming Li
   • Qianqian Ma
   • Wei Yang

   Review 26 April 2018 Pages: 2764 - 2772

3. Generalization after ocular onset in myasthenia gravis: a case series in Germany

   • Feng Li
   • Benjamin Hotter
   • Jens-C. Rückert

   Original Communication 17 September 2018 Pages: 2773 - 2782

   

4. 36-Months follow-up assessment after cessation and resuming of enzyme replacement therapy in late onset Pompe disease: data from the Swiss Pompe Registry

   • Olivier Scheidegger
   • Daniela Leupold
   • Thomas Hundsberger

   Original Communication 19 September 2018 Pages: 2783 - 2788

   

5. Identifying barriers to help-seeking for sexual dysfunction in multiple sclerosis

   • Katarina Ivana Tudor
   • S. Eames
   • J. N. Panicker

   Original Communication 19 September 2018 Pages: 2789 - 2802

6. Cerebral small vessel disease burden and functional and radiographic outcomes in intracerebral hemorrhage

   • Vasileios-Arsenios Lioutas
   • Bo Wu
   • Magdy Selim

   Original Communication 21 September 2018 Pages: 2803 - 2814

   

7. Efficacy of pregabalin in post-traumatic peripheral neuropathic pain: a randomized, double-blind, placebo-controlled phase 3 trial

   • John Markman
   • Malca Resnick
   • Lloyd Knapp

   Original Communication Open access 21 September 2018 Pages: 2815 - 2824

   

8. A closer look at ping-pong gaze: an observational study and literature review

   • Shi-Lin Yang
   • Xiang Han
   • Yan Wang

   Original Communication 25 September 2018 Pages: 2825 - 2833

   

9. Multifocal motor neuropathy in Austria: a nationwide survey of clinical features and response to treatment

   • Wolfgang N. Löscher
   • Eva-Maria Oberreiter
   • Raffi Topakian

   Original Communication Open access 26 September 2018 Pages: 2834 - 2840

   

10. Acute antiepileptic drug use in intensive care units

    • Bernd J. Vorderwülbecke
    • Gregor Lichtner
    • Martin Holtkamp

    Original Communication 26 September 2018 Pages: 2841 - 2850

    

11. No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study

    • Luca Prosperini
    • Pietro Annovazzi
    • the Italian Alemtuzumab Study Group

    Original Communication 26 September 2018 Pages: 2851 - 2860

    

12. Therapeutic regimen of l-arginine for MELAS: 9-year, prospective, multicenter, clinical research

    • Yasutoshi Koga
    • Nataliya Povalko
    • Katsunori Fujii

    Original Communication Open access 29 September 2018 Pages: 2861 - 2874

    

13. Effect of mechanical thrombectomy alone or in combination with intravenous thrombolysis for acute ischemic stroke

    • Fabrizio Sallustio
    • Giacomo Koch
    • Marina Diomedi

    Original Communication 01 October 2018 Pages: 2875 - 2880

    

14. Relation between functional connectivity and disability in multiple sclerosis: a non-linear model

    • Silvia Tommasin
    • Laura De Giglio
    • Patrizia Pantano

    Original Communication 01 October 2018 Pages: 2881 - 2892

    

15. Vitamin D for the treatment of multiple sclerosis: a meta-analysis

    • Laurie McLaughlin
    • Laura Clarke
    • Simon A. Broadley

    Original Communication 03 October 2018 Pages: 2893 - 2905

    

16. Short-term and long-term effects of immunoadsorption in refractory chronic inflammatory demyelinating polyneuropathy: a prospective study in 17 patients

    • Johannes Dorst
    • Albert C. Ludolph
    • Hayrettin Tumani

    Original Communication 06 October 2018 Pages: 2906 - 2915

    

17. The clinical features and outcome of scan-negative and scan-positive cases in suspected cauda equina syndrome: a retrospective study of 276 patients

    • Ingrid Hoeritzauer
    • Savva Pronin
    • Jon Stone

    Original Communication Open access 08 October 2018 Pages: 2916 - 2926

18. Functioning and quality of life in patients with neuropathy associated with anti-MAG antibodies

    • Yuri M. Falzone
    • Marta Campagnolo
    • Nilo Riva

    Original Communication Open access 10 October 2018 Pages: 2927 - 2933

19. The role of clinical and neuroimaging features in the diagnosis of CADASIL

    • Anna Bersano
    • Gloria Bedini
    • on behalf of Lombardia GENS-group

    Original Communication 11 October 2018 Pages: 2934 - 2943

    

20. Elevated C-reactive protein and white blood cell count at admission predict functional outcome after non-aneurysmal subarachnoid hemorrhage

    • Patrick Schuss
    • Alexis Hadjiathanasiou
    • Erdem Güresir

    Original Communication 13 October 2018 Pages: 2944 - 2948

    

21. Structural signature in SCA1: clinical correlates, determinants and natural history

    • Carlos Roberto Martins Junior
    • Alberto Rolim Muro Martinez
    • Marcondes Cavalcante França Jr

    Original Communication 15 October 2018 Pages: 2949 - 2959

    

22. Mixed TDP-43 proteinopathy and tauopathy in frontotemporal lobar degeneration: nine case series

    • Eun-Joo Kim
    • Jesse A. Brown
    • Lea T. Grinberg

    Original Communication 15 October 2018 Pages: 2960 - 2971

    

23. Perfusion-CT imaging in epileptic seizures

    • Davide Strambo
    • V. Rey
    • P. Michel

    Original Communication 16 October 2018 Pages: 2972 - 2979

    

24. Comparative effectiveness of delayed-release dimethyl fumarate versus interferon, glatiramer acetate, teriflunomide, or fingolimod: results from the German NeuroTransData registry

    • Stefan Braune
    • Sarah Grimm
    • NTD Study Group

    Original Communication Open access 16 October 2018 Pages: 2980 - 2992

    

25. Early MRI-negative posterior circulation stroke presenting as acute dizziness

    • Jae-Hwan Choi
    • Eun Hye Oh
    • Kwang-Dong Choi

    Original Communication 19 October 2018 Pages: 2993 - 3000

    

26. Serum irisin is upregulated in patients affected by amyotrophic lateral sclerosis and correlates with functional and metabolic status

    • Christian Lunetta
    • Andrea Lizio
    • Valeria Sansone

    Original Communication 22 October 2018 Pages: 3001 - 3008

    

27. Risk factors for self-harm in people with epilepsy

    • Hayley C. Gorton
    • Roger T. Webb
    • Darren M. Ashcroft

    Original Communication Open access 24 October 2018 Pages: 3009 - 3016

28. A smartphone camera reveals an ‘invisible’ Parkinsonian tremor: a potential pre-motor biomarker?

    • Stefan Williams
    • Hui Fang
    • Christopher D. Graham

    Letter to the Editors 21 September 2018 Pages: 3017 - 3018

29. Migraine prophylactic management in neurology and primary care (2006–2015)

    • Jeffrey L. Jackson
    • Cynthia Kay
    • Kathlyn Fletcher

    Letter to the Editors 19 September 2018 Pages: 3019 - 3021

30. Management of patients with stroke treated with direct oral anticoagulants

    • D. J. Seiffge
    • A. A. Polymeris
    • Gian Marco De Marchis

    Neurological Update 06 October 2018 Pages: 3022 - 3033

    

31. Nerve sheath tumours

    • James A. Robertson
    • Emma C. Tallantyre

    Journal club Open access 31 October 2018 Pages: 3034 - 3035

32. Lothar von Frankl-Hochwart (1862–1914)

    • Lazaros C. Triarhou

    Pioneers in Neurology 25 January 2018 Pages: 3036 - 3037